๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

422 Efficacy and safety of adefovir for the treatment of patients with chronic hepatitis B (CHB) resistant to lamivudine in Spain

โœ Scribed by M. Buti; R. Esteban; P. Escartin; J.L. Calleja; J. Enriquez; F. Pons; J. Crespo; M.G. Bengoechea; M. Prieto; T. Casanovas; J.G. Samaniego; M. Miras; F.P. Roldan; M. Pelaez; E. Fraga; V. Moreira; P.G. Carro; M. Rueda


Book ID
117373251
Publisher
Elsevier Science
Year
2004
Tongue
English
Weight
64 KB
Volume
40
Category
Article
ISSN
0168-8278

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Efficacy of entecavir in patients with c
โœ Ju Hyun Shim; Dong Jin Suh; Kang Mo Kim; Young-Suk Lim; Han Chu Lee; Young-Hwa C ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 287 KB ๐Ÿ‘ 1 views

Entecavir (ETV) is currently recommended as a rescue therapy purely for adefovir (ADV)resistant chronic hepatitis B virus (HBV) infections. We evaluated the efficacy of ETV in patients who were resistant to lamivudine (LAM)/ADV sequential therapy and in those resistant to LAM monotherapy. Fifty LAM/